{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T18:05:13Z","timestamp":1791223513939,"version":"4.1.0"},"update-to":[{"DOI":"10.1002\/14651858.cd001261.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2014,1,2]],"date-time":"2014-01-02T00:00:00Z","timestamp":1388620800000}}],"reference-count":123,"publisher":"Wiley","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd001261.pub3","type":"journal-article","created":{"date-parts":[[2014,1,2]],"date-time":"2014-01-02T20:32:08Z","timestamp":1388694728000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Vaccines for preventing typhoid fever"],"prefix":"10.1002","author":[{"given":"Elspeth","family":"Anwar","sequence":"first","affiliation":[{"name":"Liverpool School of Tropical Medicine; Department of Clinical Sciences; Liverpool UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elad","family":"Goldberg","sequence":"additional","affiliation":[{"name":"Beilinson Hospital, Rabin Medical Center; Department of Medicine E; 39 Jabotinski Street Petah Tikva Israel 49100"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abigail","family":"Fraser","sequence":"additional","affiliation":[{"name":"University of Bristol, Oakfield House; MRC Integrative Epidemiology Unit at the University of Bristol; Oakfield Road Bristol UK BS8 2BN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilo J","family":"Acosta","sequence":"additional","affiliation":[{"name":"Merck Global Health Outcomes Vaccines; West Point PA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mical","family":"Paul","sequence":"additional","affiliation":[{"name":"Rambam Health Care Center, Haifa, Israel and Sackler Faculty of Medicine; Unit of Infectious Diseases; Tel Aviv University Tel Aviv Israel 49100"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonard","family":"Leibovici","sequence":"additional","affiliation":[{"name":"Beilinson Hospital, Rabin Medical Center; Department of Medicine E; 39 Jabotinski Street Petah Tikva Israel 49100"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2014,1,2]]},"reference":[{"issue":"18","key":"10.1002\/14651858.CD001261.pub3-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1056\/NEJM198710293171801","article-title":"Prevention of typhoid fever in Nepal with the Vi capsular polysaccharide of Salmonella typhi: a preliminary report","volume":"317","author":"Acharya","year":"1987","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"10.1002\/14651858.CD001261.pub3-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0264-410X(90)90183-M","article-title":"Efficacy of one or two doses of Ty21a Salmonella typhi vaccine in enteric coated capsules in a controlled field trial","volume":"8","author":"Black","year":"1990","journal-title":"Vaccine"},{"key":"10.1002\/14651858.CD001261.pub3-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1086\/518141","article-title":"Ty21a live oral typhoid vaccine and prevention of paratyphoid fever caused by Salmonella enterica Serovar Paratyphi B","volume":"45(Suppl 1)","author":"Levine","year":"2007","journal-title":"Clinical Infectious Diseases"},{"key":"10.1002\/14651858.CD001261.pub3-BIB0004|cit4","unstructured":"See Black 1990i: different arm of same trial"},{"issue":"3","key":"10.1002\/14651858.CD001261.pub3-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1128\/IAI.61.3.1149-1151.1993","article-title":"Safety and immunogenicity of Salmonella typhi Ty21a vaccine in young Thai children","volume":"61","author":"Cryz","year":"1993","journal-title":"Infection and Immunity"},{"issue":"3","key":"10.1002\/14651858.CD001261.pub3-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0264-410X(94)90194-5","article-title":"Clinical and serological responses following primary and booster immunization with Salmonella typhi Vi capsular polysaccharide vaccines","volume":"12","author":"Keitel","year":"1994","journal-title":"Vaccine"},{"issue":"36","key":"10.1002\/14651858.CD001261.pub3-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"5389","DOI":"10.1016\/j.vaccine.2012.06.015","article-title":"Effectiveness of Vi capsular polysaccharide vaccine among children: a cluster randomised trial in Karachi, Pakistan","volume":"30","author":"Khan","year":"2012","journal-title":"Vaccine"},{"issue":"8569","key":"10.1002\/14651858.CD001261.pub3-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/S0140-6736(87)91316-X","article-title":"Protective activity of Vi capsular polysaccharide vaccine against typhoid fever","volume":"2","author":"Klugman","year":"1987","journal-title":"Lancet"},{"issue":"5","key":"10.1002\/14651858.CD001261.pub3-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/0264-410X(95)00186-5","article-title":"Immunogenicity, efficacy and serological correlate of protection of Salmonella typhi Vi capsular polysaccharide vaccine three years after immunization","volume":"14","author":"Klugman","year":"1996","journal-title":"Vaccine"},{"key":"10.1002\/14651858.CD001261.pub3-BIB0010|cit10","first-page":"90","article-title":"The efficacy of attenuated Salmonella typhi oral vaccine strain TY21A evaluated in controlled field trials","volume-title":"Development of Vaccines and Drugs Against Diarrhea. 11th Noble Conference, Stockholm, 1985","author":"Levine","year":"1986"},{"key":"10.1002\/14651858.CD001261.pub3-BIB0011|cit11","unstructured":"See Levine 1986i: different arm of same trial"},{"issue":"1-2","key":"10.1002\/14651858.CD001261.pub3-BIB0012|cit12","first-page":"19","article-title":"The live oral typhoid vaccine Ty21a: recent field trial results","volume":"3","author":"Germanier","year":"1986","journal-title":"Collana Monografica"},{"key":"10.1002\/14651858.CD001261.pub3-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0264-410X(99)00231-5","article-title":"Duration of efficacy of Ty21a, attenuated Salmonella typhi live oral vaccine","volume":"17(Suppl 2)","author":"Levine","year":"1999","journal-title":"Vaccine"},{"issue":"8541","key":"10.1002\/14651858.CD001261.pub3-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0140-6736(87)90480-6","article-title":"Large-scale field trial of Ty21a live oral typhoid vaccine in enteric-coated capsule formulation","volume":"1","author":"Levine","year":"1987","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD001261.pub3-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1086\/518141","article-title":"Ty21a live oral typhoid vaccine and prevention of paratyphoid fever caused by Salmonella enterica Serovar Paratyphi B","volume":"45(Suppl 1)","author":"Levine","year":"2007","journal-title":"Clinical Infectious Diseases"},{"issue":"3","key":"10.1002\/14651858.CD001261.pub3-BIB0016|cit16","first-page":"459","article-title":"The current status of typhoid vaccine development and clinical trials with typhoid vaccines","volume":"19","author":"Levine","year":"1988","journal-title":"Southeast Asian Journal of Tropical Medicine and Public Health"},{"issue":"6","key":"10.1002\/14651858.CD001261.pub3-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1097\/00006454-198906000-00010","article-title":"Typhoid vaccines come of age","volume":"8","author":"Levine","year":"1989","journal-title":"Pediatric Infectious Disease Journal"},{"key":"10.1002\/14651858.CD001261.pub3-BIB0018|cit18","unstructured":"See Levine 1987i: different arm of same trial"},{"key":"10.1002\/14651858.CD001261.pub3-BIB0019|cit19","unstructured":"See Levine 1987i: different arm of same trial"},{"key":"10.1002\/14651858.CD001261.pub3-BIB0020|cit20","unstructured":"See Levine 1987i: different arm of same trial"},{"key":"10.1002\/14651858.CD001261.pub3-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0264-410X(99)00231-5","article-title":"Duration of efficacy of Ty21a, attenuated Salmonella typhi live oral vaccine","volume":"17(Suppl 2)","author":"Levine","year":"1999","journal-title":"Vaccine"},{"issue":"8720","key":"10.1002\/14651858.CD001261.pub3-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/0140-6736(90)92266-K","article-title":"Comparison of enteric-coated capsules and liquid formulation of Ty21a typhoid vaccine in randomised controlled field trial","volume":"336","author":"Levine","year":"1990","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD001261.pub3-BIB0023|cit23","unstructured":"See Levine 1990i: different arm of same trial"},{"issue":"17","key":"10.1002\/14651858.CD001261.pub3-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1056\/NEJM200104263441701","article-title":"The efficacy of a Salmonella typhi Vi conjugate vaccine in two-to-five-year-old children","volume":"344","author":"Lin","year":"2001","journal-title":"New England Journal of Medicine"},{"issue":"14","key":"10.1002\/14651858.CD001261.pub3-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1056\/NEJM200310023491423","article-title":"Persistent efficacy of Vi conjugate vaccine against typhoid fever in young children","volume":"349","author":"Mai","year":"2003","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"10.1002\/14651858.CD001261.pub3-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1093\/infdis\/166.2.451","article-title":"Safety and immunogenicity of Salmonella typhi Ty21a liquid formulation vaccine in 4- to 6-year-old Thai children","volume":"166","author":"Olanratmanee","year":"1992","journal-title":"Journal of Infectious Diseases"},{"issue":"8774","key":"10.1002\/14651858.CD001261.pub3-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/0140-6736(91)91910-M","article-title":"Oral immunisation against typhoid fever in Indonesia with Ty21a vaccine","volume":"338","author":"Simanjuntak","year":"1991","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD001261.pub3-BIB0028|cit28","unstructured":"See Simanjuntak 1991i: different arm of same trial"},{"issue":"4","key":"10.1002\/14651858.CD001261.pub3-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1056\/NEJMoa0807521","article-title":"A cluster-randomized effectiveness trial of Vi typhoid vaccine in India","volume":"361","author":"Sur","year":"2009","journal-title":"New England Journal of Medicine"},{"issue":"5","key":"10.1002\/14651858.CD001261.pub3-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1128\/CVI.00532-10","article-title":"The Vi conjugate typhoid vaccine is safe, elicits protective levels of IgG anti-Vi, and is compatible with routine infant vaccines","volume":"18","author":"Thiem","year":"2011","journal-title":"Clinical and Vaccine Immunology"},{"issue":"3","key":"10.1002\/14651858.CD001261.pub3-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1093\/infdis\/145.3.292","article-title":"A controlled field trial of live Salmonella typhi strain Ty 21a oral vaccine against typhoid: three-year results","volume":"145","author":"Wahdan","year":"1982","journal-title":"Journal of Infectious Diseases"},{"issue":"3","key":"10.1002\/14651858.CD001261.pub3-BIB0032|cit32","first-page":"469","article-title":"A controlled field trial of live oral typhoid vaccine Ty21a","volume":"58","author":"Wahdan","year":"1980","journal-title":"Bulletin of the World Health Organization"},{"issue":"3","key":"10.1002\/14651858.CD001261.pub3-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1093\/infdis\/145.3.292","article-title":"A controlled field trial of live Salmonella typhi strain Ty 21a oral vaccine against typhoid: three year results","volume":"145","author":"Wahdan","year":"1982","journal-title":"Journal of Infectious Diseases"},{"issue":"3","key":"10.1002\/14651858.CD001261.pub3-BIB0034|cit34","first-page":"469","article-title":"A controlled field trial of live oral typhoid vaccine Ty21a","volume":"58","author":"Wahdan","year":"1980","journal-title":"Bulletin of the World Health Organization"},{"issue":"48-9","key":"10.1002\/14651858.CD001261.pub3-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"5618","DOI":"10.1016\/j.vaccine.2005.06.035","article-title":"Efficacy of a locally produced, Chinese Vi polysaccharide typhoid fever vaccine during six years of follow-up","volume":"23","author":"Acosta","year":"2005","journal-title":"Vaccine"},{"issue":"1","key":"10.1002\/14651858.CD001261.pub3-BIB0036|cit36","first-page":"26","article-title":"Efficacy and side effects following immunization with Salmonella typhi Vi capsular polysaccharide vaccine","volume":"18","author":"Wang","year":"1997","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi"},{"issue":"1","key":"10.1002\/14651858.CD001261.pub3-BIB0037|cit37","first-page":"26","article-title":"Efficacy and side effects following immunization with Salmonella typhi Vi capsular polysaccharide vaccine","volume":"18","author":"Wang","year":"1997","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi"},{"issue":"48-9","key":"10.1002\/14651858.CD001261.pub3-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"5618","DOI":"10.1016\/j.vaccine.2005.06.035","article-title":"Efficacy of a locally produced, Chinese Vi polysaccharide typhoid fever vaccine during six years of follow-up","volume":"23","author":"Acosta","year":"2005","journal-title":"Vaccine"},{"issue":"7","key":"10.1002\/14651858.CD001261.pub3-BIB0039|cit39","first-page":"625","article-title":"Efficacy trial of Vi polysaccharide vaccine against typhoid fever in south-western China","volume":"79","author":"Yang","year":"2001","journal-title":"Bulletin of the World Health Organization"},{"issue":"11","key":"10.1002\/14651858.CD001261.pub3-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1097\/INF.0b013e31812565bc","article-title":"Revaccination with locally-produced Vi typhoid polysaccharide vaccine among Chinese school-aged children: safety and immunogenicity findings","volume":"26","author":"Zhou","year":"2007","journal-title":"The Paediatric Infectious Disease Journal"},{"issue":"48","key":"10.1002\/14651858.CD001261.pub3-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"9051","DOI":"10.1016\/j.vaccine.2011.09.027","article-title":"Impact of Vi vaccination on spatial patterns of typhoid fever in the slums of Kolkata, India","volume":"29","author":"Ali","year":"2011","journal-title":"Vaccine"},{"issue":"2","key":"10.1002\/14651858.CD001261.pub3-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S0264-410X(96)00168-5","article-title":"Efficacy of Salmonella typhi Vi capsular polysaccharide vaccine in South Africa","volume":"15","author":"Arya","year":"1997","journal-title":"Vaccine"},{"key":"10.1002\/14651858.CD001261.pub3-BIB0043|cit43","first-page":"196","article-title":"Controlled field trial in British Guiana school children of heat-killed phenolized and acetone-killed lyophilized vaccines","volume":"79","author":"Ashcroft","year":"1964","journal-title":"American Journal of Hygiene"},{"issue":"7525","key":"10.1002\/14651858.CD001261.pub3-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/S0140-6736(67)90335-2","article-title":"A seven-year field trial of two typhoid vaccines in Guyana","volume":"2","author":"Ashcroft","year":"1967","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD001261.pub3-BIB0045|cit45","first-page":"631","article-title":"A controlled field trial of acetone-dried and inactivated and heat-phenol-inactivated typhoid vaccines in British Guiana","volume":"30","author":"Kasi","year":"1964","journal-title":"Bulletin of the World Health Organization"},{"key":"10.1002\/14651858.CD001261.pub3-BIB0046|cit46","first-page":"9","article-title":"Immunogenicity of Ty21a attenuated \"Salmonella typhi\" given with sodium bicarbonate or in enteric-coated capsules","volume":"53","author":"Black","year":"1983","journal-title":"Developments in Biological Standardization"},{"issue":"5-6","key":"10.1002\/14651858.CD001261.pub3-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/S0264-410X(01)00391-7","article-title":"Safety and immunogenicity of live recombinant Salmonella enterica serovar Typhi Ty21a expressing urease A and B from Helicobacter pylori in human volunteers","volume":"20","author":"Bumann","year":"2001","journal-title":"Vaccine"},{"issue":"11","key":"10.1002\/14651858.CD001261.pub3-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"6586","DOI":"10.1128\/IAI.72.11.6586-6588.2004","article-title":"Effect of dosage on immunogenicity of a Vi conjugate vaccine injected twice into 2- to 5-year-old Vietnamese children","volume":"72","author":"Canh","year":"2004","journal-title":"Infection and Immunity"},{"key":"10.1002\/14651858.CD001261.pub3-BIB0052|cit49","first-page":"98","article-title":"Controlled field trials of three different oral killed typhoid vaccines in India","volume":"33","author":"Chuttani","year":"1976","journal-title":"Developments in Biological Standardization"},{"issue":"5","key":"10.1002\/14651858.CD001261.pub3-BIB0049|cit50","first-page":"643","article-title":"Controlled field trial of a high-dose oral killed typhoid vaccine in India","volume":"55","author":"Chuttani","year":"1977","journal-title":"Bulletin of the World Health Organization"},{"issue":"6","key":"10.1002\/14651858.CD001261.pub3-BIB0050|cit51","first-page":"754","article-title":"Ineffectiveness of an oral killed typhoid vaccine in a field trial","volume":"48","author":"Chuttani","year":"1973","journal-title":"Bulletin of the World Health Organization"},{"issue":"4","key":"10.1002\/14651858.CD001261.pub3-BIB0051|cit52","first-page":"445","article-title":"Effectiveness of oral killed typhoid vaccine","volume":"45","author":"Chuttani","year":"1971","journal-title":"Bulletin of the World Health Organization"},{"key":"10.1002\/14651858.CD001261.pub3-BIB0053|cit53","doi-asserted-by":"crossref","unstructured":"Cordero-Yap L Rivera RG Dispo AP Mallabo J Evaluation of a new Vi polysaccharide typhoid vaccine in children aged 2-5 years BioDrugs 2001 27","DOI":"10.2165\/00063030-200115001-00005"},{"issue":"4","key":"10.1002\/14651858.CD001261.pub3-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1128\/IAI.63.4.1336-1339.1995","article-title":"Safety and immunogenicity of a live oral bivalent typhoid fever (Salmonella typhi Ty21a)-cholera (Vibrio cholerae CVD 103-HgR) vaccine in healthy adults","volume":"63","author":"Cryz","year":"1995","journal-title":"Infection and Immunity"},{"issue":"3","key":"10.1002\/14651858.CD001261.pub3-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1177\/030006059202000306","article-title":"Typhoid Vi: a less reactogenic vaccine","volume":"20","author":"Cumberland","year":"1992","journal-title":"Journal of International Medical Research"},{"issue":"4","key":"10.1002\/14651858.CD001261.pub3-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1093\/infdis\/159.4.766","article-title":"Comparative efficacy of two, three, or four doses of TY21a live oral typhoid vaccine in enteric-coated capsules: a field trial in an endemic area","volume":"159","author":"Ferreccio","year":"1989","journal-title":"Journal of Infectious Diseases"},{"key":"10.1002\/14651858.CD001261.pub3-BIB0057|cit57","first-page":"1","article-title":"Results of the study of typhoid vaccines in four controlled field trials in the USSR","volume":"32","author":"Hejfec","year":"1965","journal-title":"Bulletin of the World Health Organization"},{"key":"10.1002\/14651858.CD001261.pub3-BIB0058|cit58","first-page":"371","article-title":"A controlled field trial of the typhoid component of polyvalent enteric vaccine (NIISI polyvaccine)","volume":"26","author":"Khasanov","year":"1962","journal-title":"Bulletin of the World Health Organization"},{"key":"10.1002\/14651858.CD001261.pub3-BIB0060|cit59","first-page":"1","article-title":"Results of the study of typhoid vaccines in four controlled field trials in the USSR","volume":"32","author":"Hejfec","year":"1965","journal-title":"Bulletin of the World Health Organization"},{"issue":"3","key":"10.1002\/14651858.CD001261.pub3-BIB0059|cit60","first-page":"321","article-title":"A controlled field trial and laboratory study of five typhoid vaccines in the USSR","volume":"34","author":"Hejfec","year":"1966","journal-title":"Bulletin of the World Health Organization"},{"issue":"6","key":"10.1002\/14651858.CD001261.pub3-BIB0061|cit61","first-page":"907","article-title":"Controlled field trials of paratyphoid B vaccine and evaluation of the effectiveness of a single administration of typhoid vaccine","volume":"38","author":"Hejfec","year":"1968","journal-title":"Bulletin of the World Health Organization"},{"issue":"6","key":"10.1002\/14651858.CD001261.pub3-BIB0062|cit62","first-page":"903","article-title":"A controlled field trial to evaluate the protective capacity of a single dose of acetone-killed agar-grown and heat-killed broth-grown typhoid vaccines","volume":"40","author":"Hejfec","year":"1969","journal-title":"Bulletin of the World Health Organization"},{"key":"10.1002\/14651858.CD001261.pub3-BIB0063|cit63","first-page":"93","article-title":"Controlled field trials of killed oral typhoid and paratyphoid B vaccines and cell-free, chemical aerosol typhoid vaccine","volume":"33","author":"Hejfec","year":"1976","journal-title":"Developments in Biological Standardization"},{"issue":"7","key":"10.1002\/14651858.CD001261.pub3-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"e11778","DOI":"10.1371\/journal.pone.0011778","article-title":"A randomised trial evaluating the safety and immunogenicity of the novel single oral dose typhoid vaccine M01ZH09 in healthy Vietnamese children","volume":"5","author":"Hien","year":"2010","journal-title":"PloS one"},{"issue":"6","key":"10.1002\/14651858.CD001261.pub3-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1093\/infdis\/173.6.1408","article-title":"phoP\/phoQ-deleted Salmonella typhi (Ty800) is a safe and immunogenic single-dose typhoid fever vaccine in volunteers","volume":"173","author":"Hohmann","year":"1996","journal-title":"Journal of Infectious Diseases"},{"issue":"1","key":"10.1002\/14651858.CD001261.pub3-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0264-410X(95)00173-X","article-title":"Evaluation of a phoP\/phoQ-deleted, aroA-deleted live oral Salmonella typhi vaccine strain in human volunteers","volume":"14","author":"Hohmann","year":"1996","journal-title":"Vaccine"},{"issue":"4","key":"10.1002\/14651858.CD001261.pub3-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"e60583","DOI":"10.1371\/journal.pone.0060583","article-title":"Head-to-head comparison of humoral immune responses to Vi capsular polysaccharide and salmonella typhi Ty21a typhoid vaccine-a randomised trial","volume":"8","author":"Kantele","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"10.1002\/14651858.CD001261.pub3-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S0264-410X(98)00160-1","article-title":"Persistence of antibodies to the Salmonella typhi Vi capsular polysaccharide vaccine in South African school children ten years after immunization","volume":"17","author":"Keddy","year":"1999","journal-title":"Vaccine"},{"issue":"21","key":"10.1002\/14651858.CD001261.pub3-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"4175","DOI":"10.1016\/j.vaccine.2007.03.007","article-title":"Ability of SPI2 mutant of S. typhi to effectively induce antibody responses to the mucosal antigen enterotoxigenic E. coli heat labile toxin B subunit after oral delivery to humans","volume":"25","author":"Khan","year":"2007","journal-title":"Vaccine"},{"issue":"6984","key":"10.1002\/14651858.CD001261.pub3-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1136\/bmj.310.6984.908","article-title":"Safety and efficacy of combined meningococcal and typhoid vaccine","volume":"310","author":"Khoo","year":"1995","journal-title":"BMJ"},{"issue":"2","key":"10.1002\/14651858.CD001261.pub3-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.vaccine.2005.08.008","article-title":"Evaluation of Salmonella enterica serovar Typhi (Ty2 aroCssaV) M01ZH09, with a defined mutation in the Salmonella pathogenicity island 2, as a live, oral typhoid vaccine in human volunteers","volume":"24","author":"Kirkpatrick","year":"2006","journal-title":"Vaccine"},{"key":"10.1002\/14651858.CD001261.pub3-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2165\/00063030-200115001-00002","article-title":"Comparative tolerability and immunogenicity of Typherix or Typhim Vi in healthy adults: 0, 12-month and 0, 24-month administration","volume":"15(Suppl 1)","author":"Lebacq","year":"2001","journal-title":"BioDrugs"},{"issue":"6","key":"10.1002\/14651858.CD001261.pub3-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1128\/IAI.12.6.1290-1294.1975","article-title":"Vi antigen from Salmonella typhosa and immunity against typhoid fever. 11. Safety and antigenicity in humans","volume":"12","author":"Levin","year":"1975","journal-title":"Infection and Immunity"},{"issue":"20","key":"10.1002\/14651858.CD001261.pub3-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"3602","DOI":"10.1016\/j.vaccine.2010.02.017","article-title":"In a randomized, double-blinded, placebo-controlled trial, the single oral dose typhoid vaccine, M01ZH09, is safe and immunogenic at doses up to 1.7 \u00d7 10(10) colony-forming units","volume":"28","author":"Lyon","year":"2010","journal-title":"Vaccine"},{"issue":"11","key":"10.1002\/14651858.CD001261.pub3-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"4291","DOI":"10.1128\/IAI.59.11.4291-4293.1991","article-title":"Salmonella typhi Ty21a vaccine for young children","volume":"59","author":"Murphy","year":"1991","journal-title":"Infection and Immunity"},{"issue":"5","key":"10.1002\/14651858.CD001261.pub3-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/0264-410X(93)90237-R","article-title":"Clinical and immunological response to typhoid vaccination with parenteral or oral vaccines in two groups of 30 recruits","volume":"11","author":"Nisini","year":"1993","journal-title":"Vaccine"},{"issue":"9","key":"10.1002\/14651858.CD001261.pub3-BIB0077|cit77","first-page":"811","article-title":"Comparison of safety and immunogenicity of a Vi polysaccharide typhoid vaccine with a whole-cell killed vaccine in Malaysian Air Force recruits","volume":"79","author":"Panchanathan","year":"2001","journal-title":"Bulletin of the World Health Organization"},{"issue":"2","key":"10.1002\/14651858.CD001261.pub3-BIB0078|cit78","first-page":"211","article-title":"Controlled field trials and laboratory studies on the effectiveness of typhoid vaccines in Poland, 1961-64","volume":"34","author":"Polish Typhoid Committee","year":"1966","journal-title":"Bulletin of the World Health Organization"},{"issue":"4","key":"10.1002\/14651858.CD001261.pub3-BIB0079|cit79","first-page":"141","article-title":"Comparison of the immunogenicity and safety of two different brands of Salmonella typhi Vi capsular polysaccharide vaccine","volume":"58","author":"Sabitha","year":"2004","journal-title":"Indian Journal of Medical Sciences"},{"issue":"2","key":"10.1002\/14651858.CD001261.pub3-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1128\/IAI.60.2.536-541.1992","article-title":"Comparison of the safety and immunogenicity of delta aroC delta aroD and delta cya delta crp Salmonella typhi strains in adult volunteers","volume":"60","author":"Tacket","year":"1992","journal-title":"Infection and Immunity"},{"issue":"2","key":"10.1002\/14651858.CD001261.pub3-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1128\/IAI.65.2.452-456.1997","article-title":"Safety of live oral Salmonella typhi vaccine strains with deletions in htrA and aroC aroD and immune response in humans","volume":"65","author":"Tacket","year":"1997","journal-title":"Infection and Immunity"},{"issue":"3","key":"10.1002\/14651858.CD001261.pub3-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1128\/IAI.68.3.1196-1201.2000","article-title":"Phase 2 clinical trial of attenuated Salmonella enterica serovar typhi oral live vector vaccine CVD 908-htrA in U.S. volunteers","volume":"68","author":"Tacket","year":"2000","journal-title":"Infection and immunity"},{"issue":"1","key":"10.1002\/14651858.CD001261.pub3-BIB0083|cit83","first-page":"75","article-title":"Controlled field trial on the effectiveness of one and two doses of acetone-inactivated and dried vaccine","volume":"52","author":"Tapa","year":"1975","journal-title":"Bulletin of the World Health Organization"},{"issue":"3","key":"10.1002\/14651858.CD001261.pub3-BIB0084|cit84","first-page":"515","article-title":"The feasibility of a school-based VI polysaccharide vaccine mass immunization campaign in Hue City, central Vietnam: streamlining a typhoid fever preventive strategy","volume":"37","author":"Thiem","year":"2006","journal-title":"The Southeast Asian Journal of Tropical Medicine and Public Health"},{"issue":"9","key":"10.1002\/14651858.CD001261.pub3-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"e25398","DOI":"10.1371\/journal.pone.0025398","article-title":"Safety, immunogenicity and dose ranging of a new Vi-CRM(1)(9)(7) conjugate vaccine against typhoid fever: randomized clinical testing in healthy adults","volume":"6","author":"Damme","year":"2011","journal-title":"PLoS One"},{"issue":"1","key":"10.1002\/14651858.CD001261.pub3-BIB0086|cit86","first-page":"69","article-title":"Controlled field trial of a typhoid vaccine prepared with a nonmotile mutant of Salmonella typhi Ty2","volume":"52","author":"Wahdan","year":"1975","journal-title":"Bulletin of the World Health Organization"},{"issue":"2","key":"10.1002\/14651858.CD001261.pub3-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.clim.2010.11.006","article-title":"Oral priming with Salmonella Typhi vaccine strain CVD 909 followed by parenteral boost with the S. Typhi Vi capsular polysaccharide vaccine induces CD27+IgD-S. Typhi-specific IgA and IgG B memory cells in humans","volume":"138","author":"Wahid","year":"2011","journal-title":"Clinical Immunology"},{"issue":"1","key":"10.1002\/14651858.CD001261.pub3-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/1471-2458-5-49","article-title":"A mass vaccination campaign targeting adults and children to prevent typhoid fever in Hechi; expanding the use of Vi polysaccharide vaccine in Southeast China: a cluster-randomized trial","volume":"5","author":"Yang","year":"2005","journal-title":"BMC Public Health"},{"key":"10.1002\/14651858.CD001261.pub3-BIB0089|cit89","first-page":"699","article-title":"Immediate adverse reaction after mass vaccination of groups A+C meningococcal polysaccharide vaccine","volume":"7","author":"Yang","year":"2009","journal-title":"Chinese Journal of Biologicals"},{"key":"10.1002\/14651858.CD001261.pub3-BIB0090|cit90","first-page":"357","article-title":"A controlled field trial of the effectiveness of phenol and alcohol typhoid vaccines: final report","volume":"26","author":"Yugoslav Typhoid Commission","year":"1962","journal-title":"Bulletin of the World Health Organization"},{"key":"10.1002\/14651858.CD001261.pub3-BIB0091|cit91","first-page":"897","article-title":"Field and laboratory studies with typhoid vaccines. A preliminary report","volume":"16","author":"Yugoslav Typhoid Commission","year":"1957","journal-title":"Bulletin of the World Health Organization"},{"key":"10.1002\/14651858.CD001261.pub3-BIB0092|cit92","first-page":"623","article-title":"A controlled field trial of the effectiveness of acetone-dried and inactivated and heat-phenol-inactivated typhoid vaccines in Yugoslavia","volume":"30","author":"Yugoslav Typhoid Commission","year":"1964","journal-title":"Bulletin of the World Health Organization"},{"issue":"5","key":"10.1002\/14651858.CD001261.pub3-BIB0093|cit93","first-page":"425","article-title":"Adverse reaction and immune effect of typhoid Vi polysaccharide vaccine.","volume":"21","author":"Zhou","year":"2008","journal-title":"Chinese Journal of Biologicals"},{"key":"10.1002\/14651858.CD001261.pub3-BIB0094|cit94","article-title":"A clinical trial to study the optimal use of conjugate typhoid vaccine-single dose vs two doses","author":"Chinnasami","journal-title":"CTRI identifier: CTRI\/2010\/091\/003031"},{"key":"10.1002\/14651858.CD001261.pub3-BIB0095|cit95","unstructured":"Darton T Pollard A (overall contacts) Understanding Typhoid Disease After Vaccination: A Single Centre, Randomised, Doubleblind, Placebo Controlled Study to Evaluate M01ZH09 in a Healthy Adult Challenge Model, Using Ty21a Vaccine as a Positive Control NCT Identifier: NCT01405521"},{"key":"10.1002\/14651858.CD001261.pub3-BIB0096|cit96","unstructured":"House H (Overall contact) A phase II, single-centre, randomised, single-blind, study to evaluate Vi-CRM197 against historical unvaccinated controls in a healthy adult challenge model, with a Vi-PS vaccine control arm-Understanding immunity after typhoid vaccination EUCTR Identifier: EUCTR2011-003653-26-GB"},{"key":"10.1002\/14651858.CD001261.pub3-BIB0097|cit97","article-title":"Incidence of typhoid fever as observed over 1 year in children aged 6 months-12 years after receiving conjugated typhoid vaccine (Peda Typh TM) versus a similar non-vaccinated group in the same locality in Kolkata","author":"Mitra","journal-title":"CTRI Identifier: CTRI\/2012\/06\/002719"},{"key":"10.1002\/14651858.CD001261.pub3-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/00019048-199503000-00011","article-title":"Immunization against Salmonella typhi","volume":"4","author":"Bennish","year":"1995","journal-title":"Infectious Diseases in Clinical Practice"},{"issue":"9487","key":"10.1002\/14651858.CD001261.pub3-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/S0140-6736(05)67181-4","article-title":"Typhoid and paratyphoid fever","volume":"366","author":"Bhan","year":"2005","journal-title":"Lancet"},{"issue":"3","key":"10.1002\/14651858.CD001261.pub3-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1136\/adc.75.3.214","article-title":"Impact of age and drug resistance on mortality in typhoid fever","volume":"75","author":"Bhutta","year":"1996","journal-title":"Archives of Diseases of Childhood"},{"issue":"1","key":"10.1002\/14651858.CD001261.pub3-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"e29119","DOI":"10.1371\/journal.pone.0029119","article-title":"Population-based incidence of typhoid fever in an urban informal settlement and a rural area in Kenya: implications for typhoid vaccine use in Africa","volume":"7","author":"Breiman","year":"2012","journal-title":"PLoS One"},{"issue":"5","key":"10.1002\/14651858.CD001261.pub3-BIB0102|cit102","first-page":"346","article-title":"The global burden of typhoid fever","volume":"82","author":"Crump","year":"2004","journal-title":"Bulletin of the World Health Organization"},{"issue":"2","key":"10.1002\/14651858.CD001261.pub3-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1086\/649541","article-title":"Global trends in typhoid and paratyphoid fever","volume":"50","author":"Crump","year":"2010","journal-title":"Clinical Infectious Disease"},{"issue":"5","key":"10.1002\/14651858.CD001261.pub3-BIB0104|cit104","first-page":"547","article-title":"Typhoid vaccination: the Asian experience","volume":"7","author":"Deroeck","year":"2008","journal-title":"Vaccines"},{"issue":"4","key":"10.1002\/14651858.CD001261.pub3-BIB0105|cit105","first-page":"339","article-title":"Salmonella vaccines for use in humans: present and future perspectives","volume":"26","author":"Garmory","year":"2002","journal-title":"FEMS Microbiology Reviews"},{"issue":"7650","key":"10.1002\/14651858.CD001261.pub3-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD001261.pub3-BIB0107|cit107","unstructured":"Higgins JPT Green S Highly sensitive search strategies for identifying reports of randomized controlled trials in MEDLINE Cochrane Handbook for Systematic Reviews of Interventions 4.2.6 [updated September 2006]; Appendix 5b. www.cochrane.org\/resources\/handbook\/hbook.htm"},{"issue":"7303","key":"10.1002\/14651858.CD001261.pub3-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1136\/bmj.323.7303.42","article-title":"Systematic reviews in healthcare: assessing the quality of controlled trials","volume":"323","author":"J\u00fcni","year":"2001","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD001261.pub3-BIB0109|cit109","volume-title":"Mandell, Douglas, and Bennett's principles and practice of infectious diseases","author":"Mandell","year":"2005"},{"key":"10.1002\/14651858.CD001261.pub3-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0140-6736(12)60294-3","article-title":"A first step in bringing typhoid fever out of the closet","volume":"379","author":"Maurice","year":"2012","journal-title":"The Lancet"},{"issue":"4","key":"10.1002\/14651858.CD001261.pub3-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"260","DOI":"10.2471\/BLT.06.039818","article-title":"A study of typhoid fever in five Asian countries: disease burden and implications for controls","volume":"86","author":"Ochiai","year":"2008","journal-title":"Bulletin of the World Health Organisation"},{"issue":"(Suppl 1)","key":"10.1002\/14651858.CD001261.pub3-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1086\/518144","article-title":"The use of typhoid vaccines in Asia: the DOMI experience","volume":"45","author":"Ochiai","year":"2007","journal-title":"Clinical Infectious Diseases"},{"issue":"22","key":"10.1002\/14651858.CD001261.pub3-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1056\/NEJMra020201","article-title":"Typhoid fever","volume":"347","author":"Parry","year":"2002","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD001261.pub3-BIB0114|cit114","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2008"},{"issue":"5","key":"10.1002\/14651858.CD001261.pub3-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/00006454-200105000-00010","article-title":"Typhoid fever in Bangladesh: implications for vaccination policy","volume":"20","author":"Saha","year":"2001","journal-title":"Pediatric Infectious Disease Journal"},{"issue":"9180","key":"10.1002\/14651858.CD001261.pub3-BIB0116|cit116","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/S0140-6736(98)09001-1","article-title":"Typhoid fever in children aged less than 5 years","volume":"354","author":"Sinha","year":"1999","journal-title":"Lancet"},{"issue":"32","key":"10.1002\/14651858.CD001261.pub3-BIB0117|cit117","first-page":"257","article-title":"Typhoid vaccines: WHO position paper","volume":"75","author":"World Health Organization","year":"2000","journal-title":"Weekly Epidemiological Record"},{"key":"10.1002\/14651858.CD001261.pub3-BIB0118|cit118","article-title":"1. Diarrhoeal diseases [www.who.int\/vaccine_research\/documents\/Diarrhoeal_Diseases.pdf]","volume-title":"State of the Art of Vaccine Research and Development [WHO\/IVB\/05.XX]","author":"Initiative for Vaccines Research","year":"2005"},{"issue":"6","key":"10.1002\/14651858.CD001261.pub3-BIB0119|cit119","first-page":"49","article-title":"Typhoid vaccine: WHO position paper","volume":"83","author":"World Health Organisation","year":"2008","journal-title":"Weekly Epidemiological Record"},{"issue":"4","key":"10.1002\/14651858.CD001261.pub3-BIB0120|cit120","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001261","article-title":"Vaccines for preventing typhoid fever","author":"Engels","year":"1998","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7125","key":"10.1002\/14651858.CD001261.pub3-BIB0121|cit121","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1136\/bmj.316.7125.110","article-title":"Typhoid fever vaccines: a meta-analysis of efficacy and toxicity studies","volume":"316","author":"Engels","year":"1998","journal-title":"BMJ"},{"issue":"4. Art No: CD00","key":"10.1002\/14651858.CD001261.pub3-BIB0122|cit122","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001261.pub2","article-title":"Vaccines for preventing typhoid fever","author":"Fraser","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"45","key":"10.1002\/14651858.CD001261.pub3-BIB0123|cit123","doi-asserted-by":"crossref","first-page":"7848","DOI":"10.1016\/j.vaccine.2007.08.027","article-title":"Typhoid fever vaccines: systematic review and meta-analysis of randomised controlled trials","volume":"25","author":"Fraser","year":"2007","journal-title":"Vaccine"}],"updated-by":[{"DOI":"10.1002\/14651858.cd001261.pub4","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2018,5,31]],"date-time":"2018-05-31T00:00:00Z","timestamp":1527724800000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD001261.pub3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T21:01:15Z","timestamp":1628542875000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD001261.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Infectious Diseases Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,1,2]]},"references-count":123,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd001261.pub3","relation":{"new_version":[{"id-type":"doi","id":"10.1002\/14651858.CD001261.pub4","asserted-by":"object"}]},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,2]]}}}